"We have reached an agreement to receive doses of the Sputnik V vaccine in the future," Paris told reporters on Tuesday.
At the moment, Chile has two vaccines in use — ones of US company Pfizer and China's Sinovac.
Sputnik V was developed by the Moscow-based Gamaleya Institute and officially registered for emergency use in Russia on 11 August. Last week, peer-reviewed medical journal The Lancet published an interim analysis from phase 3 trial of the vaccine, showing its 91.6 percent efficacy against symptomatic COVID-19.
The Russian vaccine has already been approved in over 20 other countries, including Belarus, Serbia, Argentina, Bolivia, Mexico, Iran, Nicaragua, Algeria, Lebanon, Palestine, Venezuela, Paraguay, Hungary, the UAE and others.
